Multidisciplinary Training Program in Pediatric Pulmonary

小儿肺科多学科培训计划

基本信息

  • 批准号:
    10207735
  • 负责人:
  • 金额:
    $ 33.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary The goals of the Johns Hopkins Multidisciplinary Training Program in Pediatric Pulmonary Medicine (T32) are to: (1) produce outstanding biomedical scientists who will investigate the pathophysiology and treatment of pediatric pulmonary disorders; (2) encourage and enable post-doctoral fellows to pursue academic careers in clinical and biomedical research; (3) train physician-fellows to fill one of the most important health-related needs of the nation: translational medical research with a focus on pediatric pulmonology; and (4) develop national leaders in pediatric pulmonology. The program is committed to equal opportunity for its faculty, staff and students and does not discriminate on the basis of any legally protected characteristics. The proposed training program will provide three years of training in pediatric lung-related research at the postdoctoral level for qualified candidates with an MD, MD/PhD, or DO degree and 1-3 years of training for qualified candidates with PhD degrees. We are requesting support for 4 post-doctoral fellows/year. This training program is the result of an extensive collaboration between 25 research faculty members in the Johns Hopkins School of Medicine's Departments of Pediatrics, Medicine and Nanomedicine. These research scientists offer mentored training in five Research Discipline Groups: (1) cystic fibrosis, epithelial transport, mucus rheology and transport ; (2) lung injury and development; (3) clinical outcomes in pediatric pulmonary diseases; (4) infectious diseases, tuberculosis and global health; and (5) asthma, allergy and inflammation. The tutorial relationship between research-preceptor and trainee will be central to the program's research training experience. This will be supplemented by formal training in clinical investigation, preparation of grant applications and the responsible conduct of research, participation in program-wide conferences, presentation of original research at national scientific meetings and publication of original research in peer-reviewed journals. The Program Director will have overall responsibility for coordination of the program, including its scientific, educational and administrative aspects. She will receive consultation from an Advisory Committee and from Minority Advisory and External Advisory Committees. The Program Director will be assisted in the day-to-day operations of the program by the Chair of the Advisory Committee, who will oversee the research training of this T32 program and by the head of Fellow Education and Division Administrators. Although only 14 years old, this Multidisciplinary Training Program in Pediatric Pulmonary Medicine (T32) at Johns Hopkins has graduated 16 highly trained physician-researchers in pediatric pulmonology, 12 of whom are establishing research programs as faculty members in academic institutions in the US. This high performance record will be continued in the proposed program.
项目摘要 约翰霍普金斯多学科培训计划在儿科肺医学(T32)的目标是 (1)培养杰出的生物医学科学家,他们将研究病理生理学和治疗 儿科肺部疾病;(2)鼓励和使博士后研究员从事学术事业, 临床和生物医学研究;(3)培训医师研究员,以填补最重要的健康相关的一个 国家的需要:以儿科肺病学为重点的转化医学研究;(4)发展 儿科肺病学的国家领导人该计划致力于为教职员工提供平等的机会, 和学生,不歧视任何受法律保护的特征。拟议 培训计划将提供三年的博士后水平的儿科肺相关研究培训 对于具有MD,MD/PhD或DO学位的合格候选人,以及1-3年的合格培训 具有博士学位的候选人。我们正在申请每年4名博士后研究员的支持。本次培训 该计划是约翰霍普金斯大学25名研究教员广泛合作的结果。 霍普金斯医学院儿科、内科和纳米医学系。这些研究 科学家们在五个研究学科组提供指导培训:(1)囊性纤维化,上皮细胞 运输,粘液流变学和运输;(2)肺损伤和发育;(3)临床结局 儿科肺部疾病;(4)传染病、结核病和全球健康;以及(5)哮喘、过敏 和炎症。研究导师和受训者之间的导师关系将是 项目的研究培训经验。这将通过临床研究的正式培训进行补充, 准备赠款申请和负责任地开展研究,参与整个方案 会议、在国家科学会议上展示原创研究并出版原创作品 在同行评审的期刊上进行研究。项目主任将全面负责协调 该计划,包括其科学,教育和行政方面。她将接受咨询 咨询委员会、少数民族咨询委员会和外部咨询委员会。程序 主任将协助该计划的日常运作由主席的咨询 委员会,谁将监督这个T32计划的研究培训和研究员教育的负责人 和部门管理人员。虽然只有14岁,这个多学科的培训计划在儿科 肺部医学(T32)在约翰霍普金斯毕业16名训练有素的医生,研究人员在 儿科肺病学,其中12人正在建立研究计划,作为学术成员 在美国的机构。这一高性能记录将在拟议的方案中继续保持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Michael Collaco其他文献

Joseph Michael Collaco的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Michael Collaco', 18)}}的其他基金

The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
  • 批准号:
    10663469
  • 财政年份:
    2023
  • 资助金额:
    $ 33.36万
  • 项目类别:
Gene-Environment Interactions in Cystic Fibrosis Lung Disease
囊性纤维化肺病中的基因-环境相互作用
  • 批准号:
    9236216
  • 财政年份:
    2016
  • 资助金额:
    $ 33.36万
  • 项目类别:
Multidisciplinary Training Program in Pediatric Pulmonary
小儿肺科多学科培训计划
  • 批准号:
    10453782
  • 财政年份:
    2003
  • 资助金额:
    $ 33.36万
  • 项目类别:

相似国自然基金

胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 批准年份:
    2004
  • 资助金额:
    18.0 万元
  • 项目类别:
    面上项目

相似海外基金

Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
  • 批准号:
    MR/Y003683/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
Uncovering the epigenetic face of lung fibrosis for discovery of novel biomarkers and treatments.
揭示肺纤维化的表观遗传面,以发现新的生物标志物和治疗方法。
  • 批准号:
    MR/X032914/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Fellowship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
  • 批准号:
    MR/Y012682/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Research Grant
気道上皮バリアに着目した肺NTM症Lung-on-a-chipモデルの構築と応用
关注气道上皮屏障的肺NTM疾病芯片肺模型的构建与应用
  • 批准号:
    24K19096
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
Interaction between immunity and airway remodelling in lung disease.
肺部疾病中免疫与气道重塑之间的相互作用。
  • 批准号:
    502582
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
  • 批准号:
    BB/Y004183/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Research Grant
Tractable human distal lung organoid model as a new efficient tool to study mesenchymal-epithelial interactions in COPD
易处理的人远端肺类器官模型作为研究慢性阻塞性肺病间充质-上皮相互作用的新有效工具
  • 批准号:
    NC/Y500641/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Training Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.36万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了